Wiltrom Co., Ltd. (TPEX:6767)
Taiwan
· Delayed Price · Currency is TWD 29.45
0.00 (0.00%)
Mar 9, 2026, 12:36 PM CST
Wiltrom Revenue
In the year 2025, Wiltrom had annual revenue of 311.77M TWD, down -5.89%. Wiltrom had revenue of 64.32M in the quarter ending December 31, 2025, a decrease of -29.25%.
Revenue
311.77M
Revenue Growth
-5.89%
P/S Ratio
3.70
Revenue / Employee
6.11M
Employees
51
Market Cap
1.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 311.77M | -19.51M | -5.89% |
| Dec 31, 2024 | 331.28M | 54.17M | 19.55% |
| Dec 31, 2023 | 277.11M | 70.25M | 33.96% |
| Dec 31, 2022 | 206.86M | 62.37M | 43.16% |
| Dec 31, 2021 | 144.50M | 42.13M | 41.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AViTA | 896.85M |
| S&S Healthcare Holding | 205.64M |
| Bioptik Technology Incorporation | 837.19M |
| Cowealth Medical Holding | 3.41B |
| AmCad BioMed | 30.44M |
| Radiant Innovation | 413.06M |
| Rossmax International | 3.80B |
| Taiwan Biomaterial | 203.27M |